文章摘要
刘森元,赵静,沈慧煌,李林峰,徐萍萍,李春晓.政策工具视角下我国中药追溯体系政策研究[J].中国药事,2023,(6):664-673
政策工具视角下我国中药追溯体系政策研究
Study on the Traditional Chinese Medicine Traceability System Policy Texts in China from the Perspective of Policy Tools
投稿时间:2022-08-24  
DOI:10.16153/j.1002-7777.2023.06.005
中文关键词: 中药追溯  质量追溯  政策工具  利益相关者  政策分析
英文关键词: traditional Chinese medicine traceability system  quality traceability  policy tools  stakeholder  policy analysis
基金项目:省部级纵向项目“2021年卫生健康工作建议提案分析研究”(编号 BUCM-2021-KJ-GL0031)
作者单位
刘森元 北京中医药大学管理学院,北京 102488 
赵静 北京中医药大学管理学院,北京 102488 
沈慧煌 北京中医药大学管理学院,北京 102488 
李林峰 北京中医药大学管理学院,北京 102488 
徐萍萍 北京中医药大学管理学院,北京 102488 
李春晓 北京中医药大学管理学院,北京 102488 
摘要点击次数: 503
全文下载次数: 353
中文摘要:
      目的:分析我国中药追溯体系相关政策文本,探讨现有政策现状及倾向,为我国未来中药追溯体系政策制定及优化提供参考依据。方法:选取29份中药追溯体系相关政策为研究对象,采用内容分析法,基于政策工具及利益相关者2个维度进行分析。结果:政策工具维度中,命令与规制型、激励型、 能力建设型、系统变革型、信息与劝诫型工具分别占51.7%、12.2%、22.0%、1.0%、13.2%;利益相关者维度中,政府相关部门、中药生产企业、中药经营企业、医疗机构、消费者分别占45.2%、21.5%、 21.5%、6.3%、5.6%。结论:政策工具结构失衡,内部子工具使用不协调,利益相关者分布不均,应结合中药追溯体系相关政策特征及发展趋势,多元化使用政策工具,优化其内部结构,兼顾各利益相关方,增强主体凝聚力。
英文摘要:
      Objective: By analyzing the relevant policy texts on traditional Chinese medicine traceability system in China, this study discusses the current policy status and development tendency, which is aims to provide reference for formulation and optimization of traditional Chinese medicine traceability system policy in the future. Methods: Using the content analysis method, 29 policies related to traditional Chinese medicine traceability system were selected as research objects based on the two dimensions of policy tools and stakeholders. Results: In the dimension of policy tools, command and regulation, incentive, capacity building, system transformation, information and exhortation tools account for 51.7%, 12.2%, 22.0%, 1.0% and 13.2% respectively. In the dimension of stakeholders, relevant government departments, TCM production manufacturers, TCM distributors, medical institutions and consumers accounted for 45.2%, 21.5%, 21.5%, 6.3% and 5.6% respectively. Conclusion: The structure of policy tools is unbalanced, the use of internal policy tools is uncoordinated and the distribution of stakeholder is uneven. We should combine the relevant policy characteristics and development trends of the traditional Chinese medicine traceability system, use policy tools in a diversifi ed way, optimize its internal structure, take into account all stakeholders, and enhance the cohesion of the main body.
查看全文   查看/发表评论  下载PDF阅读器
关闭